BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Oramed Pharmaceuticals Inc. 

2 Elza Street

Jerusalem    93706  Israel
Phone: 011-972-54-7909058 Fax: 011-972-2-6792336


SEARCH JOBS




Industry
Biotechnology






 Company News
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent In Hong Kong For Oral Administration Of Insulin 4/10/2014 9:57:37 AM    More...
LifeSci Advisors Initiates Coverage Of Oramed Pharmaceuticals Inc. (ORMP) 3/21/2014 9:30:24 AM    More...
Oramed Pharmaceuticals Inc. (ORMP) to Present At Upcoming Conferences 3/6/2014 7:09:50 AM    More...
Oramed Pharmaceuticals Inc. (ORMP) To Present Results From Its Phase 2a FDA Trial With ORMD-0801 At The 2014 Diabetes Summit On April 24, 2014 3/3/2014 7:09:39 AM    More...
Oramed Pharmaceuticals Inc. (ORMP) Submits Phase 2a Protocol To FDA For The Treatment Of Type 1 Diabetes With Its Oral Insulin Capsule 2/10/2014 10:01:25 AM    More...
Oramed Pharmaceuticals Inc. (ORMP) Announces Successful FDA Phase 2a Clinical Trial Results 1/30/2014 6:40:25 AM    More...
Oramed Pharmaceuticals Inc. (ORMP) Receives Patent Allowance In Israel And Australia For Platform Technology In Oral Delivery Of Proteins 1/2/2014 8:59:08 AM    More...
Oramed Pharmaceuticals Inc. (ORMP) Nets $15.8 Million In Direct Offering To Investors 12/26/2013 8:59:14 PM    More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Announces Successful Results From Ex-US Pharmacokinetic Study Of Its Oral Insulin For The Treatment Of Type 1 Diabetes 12/20/2013 12:25:23 PM    More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Receives Patent In The European Union For the Oral Delivery of Insulin 11/19/2013 11:38:56 AM    More...
12345678910...